0
     

Report Added
Report already added
Pharmaceutical Export Market in India 2021

Pharmaceutical Export Market in India 2021

Market insights:
The pharmaceutical industry has witnessed rapid growth in the past few decades and is expected to develop further, owing to huge export possibilities. The business caters to 50% of the global demand of various vaccines, 40% of generic medicines demand in the US, and 25% of all medication in the UK. Pharmaceutical exports rose by 24.48% between FY 2020 and FY 2021 to reach INR 1,437.38 Bn in FY 2021. This was despite the global industry reduced by almost 2% in 2020 on account of COVID-19. As of 2021, nearly all medicines made domestically were low-cost generic drugs that comprise most of pharmaceutical export of the country.

Impact of COVID-19:
The onslaught of COVID-19 and the nationwide lockdown severely impacted the healthcare and pharmaceutical infrastructure, and the country’s economy. Travel restrictions, shortage of workforce, disruption in world trade, and bottleneck in logistics impacted the supply chain of pharmaceutical products. During the second wave, key market players took major steps as per regulatory guidelines with smart solutions to tackle the supply-demand gap. As of 2021, India shipped over INR 1,349 Bn worth drugs to over 200 nations, ranging from the highly regulated markets in North America and Europe to countries with small pharmaceutical markets.

Competitive insights:
Major players such as Sun Pharmaceuticals Industries Limited, Aurobindo Pharma Limited, Lupin Limited, and Dr. Reddy’s Laboratories Limited have made huge strides in their net revenue. This is because of government initiatives that propelled export possibilities.
Table of Contents

Chapter 1: Executive summary

Chapter 2: Socio-economic indicators

Chapter 3: Introduction
3.1. Market definition and structure

Chapter 4: Market overview
4.1. Pharmaceutical export market in India – An overview
4.2. Export of pharmaceutical products (FY 2018 – FY 2021)
4.3. Country-wise export of pharmaceutical products (FY 2020 – FY 2021)

Chapter 5: COVID-19 impact assessment
5.1. Overview
5.1.1. Positive impact
5.1.2. Negative impact
5.2. Post-pandemic scenario

Chapter 6: Trade analysis

6.1. Export of pharmaceutical products
6.1.1. Commodity-wise export – Based on value
6.1.2. Country-wise export – Based on value
6.1.3. Other exports – Based on value


Chapter 7: Market influencers
7.1. Market drivers
7.2. Market challenges

Chapter 8: Government initiatives

8.1 Government initiatives

Chapter 9: Competitive landscape
9.1. Sun Pharmaceuticals Industries Limited
Company information
Business description
Products/services
Key people
Financial snapshot
Key business segments
Key geographic segments
Note: Financial information covered only for public companies
9.2. Aurobindo Pharma Limited
9.3. Lupin Limited
9.4. Dr. Reddy’s Laboratories Limited
9.5. Cipla Limited
9.6. Cadila Healthcare Limited
9.7. Glenmark Pharmaceuticals Limited
9.8. Torrent Pharmaceuticals Limited
9.9. Alkem Laboratories Limited
9.10. Divi’s Laboratories Limited

Chapter 9: Recent developments
9.1. Recent developments

Chapter 10: Appendix
10.1. Research methodology
10.2. About Netscribes
10.3. Disclaimer

Companies profiled
•Sun Pharmaceuticals Industries Limited
•Aurobindo Pharma Limited
•Lupin Limited
•Dr. Reddy’s Laboratories Limited
•Cipla Limited
•Cadila Healthcare Limited
•Glenmark Pharmaceuticals Limited
•Torrent Pharmaceuticals Limited
•Alkem Laboratories Limited
•Divi’s Laboratories Limited

Report Title: Pharmaceutical Export Market in India 2021


Your Details
Valid Invalid number

Related Report

2022-2027 India Transfusion Diagnostics Market Opportunities, 2022 Shares and Five-Year Forecasts--Immunohematology and Infectious Disease Screening Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2022-2027 India Transfusion Diagnostics Market Opportunities, 2022 Shares and Five-Year Forecasts--Immunohematology and Infectious Disease Screening Analyzers and Reagents--Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts by Test, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers


India Blood Bags Market, By Product (Single Blood Bag, Triple Blood Bag, Double Blood Bag, Quadruple Blood Bag, Penta Blood Bag), By Type (Collection Bag v/s Transfer Bag), By Volume (450ml, 350ml, 150ml, 100ml, 250ml, Others), By Material (PVC, PET, Others), By End-User (Hospitals and Clinics, Blood Banks, Ambulatory Surgical Centers, Others), By Region, Competition, Forecast & Opportunities, 2018-2028F

India Blood Bags Market, By Product (Single Blood Bag, Triple Blood Bag, Double Blood Bag, Quadruple Blood Bag, Penta Blood Bag), By Type (Collection Bag v/s Transfer Bag), By Volume (450ml, 350ml, 150ml, 100ml, 250ml, Others), By Material (PVC, PET, Others), By End-User (Hospitals and Clinics, Blood Banks, Ambulatory Surgical Centers, Others), By Region, Competition, Forecast & Opportunities, 2018-2028F


2022-2026 India Cancer Diagnostics Market--Sales and Market Shares for Reagent and Instrument Suppliers, Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers

2022-2026 India Cancer Diagnostics Market--Sales and Market Shares for Reagent and Instrument Suppliers, Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers


2021-2026 India Blood Typing, Grouping and Infectious Disease NAT Screening Market--Supplier Shares, Volume and Sales Segment Forecasts for over 40 Individual Tests

2021-2026 India Blood Typing, Grouping and Infectious Disease NAT Screening Market--Supplier Shares, Volume and Sales Segment Forecasts for over 40 Individual Tests


India Generics Market Summary, Competitive Analysis and Forecast, 2017-2026

India Generics Market Summary, Competitive Analysis and Forecast, 2017-2026


India Genetic Testing Market By Type (Cytogenetic Testing, Biochemical Testing, Molecular Testing), By Application (Reproductive Cancer Screening, Ancestry Testing, Predictive and Pre-symptomatic Testing, Others), By Region, Competition, Forecast & Opportunities, 2018-2028

India Genetic Testing Market By Type (Cytogenetic Testing, Biochemical Testing, Molecular Testing), By Application (Reproductive Cancer Screening, Ancestry Testing, Predictive and Pre-symptomatic Testing, Others), By Region, Competition, Forecast & Opportunities, 2018-2028


SELECT A FORMAT

ADD TO CART BUY NOW